androstane-3,17-diol has been researched along with Prostatic Diseases in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (50.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bauman, DR; Peehl, DM; Penning, TM; Steckelbroeck, S; Williams, MV | 1 |
Alroy, J; Merk, FB; Orgad, U; Ucci, A | 1 |
1 review(s) available for androstane-3,17-diol and Prostatic Diseases
Article | Year |
---|---|
Histochemical studies of epithelial cell glycoconjugates in atrophic, metaplastic, hyperplastic, and neoplastic canine prostate.
Topics: Androstane-3,17-diol; Animals; Binding, Competitive; Carbohydrates; Castration; Cell Differentiation; Dihydrotestosterone; Dog Diseases; Dogs; Epithelium; Estradiol; Histocytochemistry; Male; Prostate; Prostatic Diseases; Prostatic Hyperplasia; Prostatic Neoplasms; Receptors, Mitogen | 1984 |
1 other study(ies) available for androstane-3,17-diol and Prostatic Diseases
Article | Year |
---|---|
Identification of the major oxidative 3alpha-hydroxysteroid dehydrogenase in human prostate that converts 5alpha-androstane-3alpha,17beta-diol to 5alpha-dihydrotestosterone: a potential therapeutic target for androgen-dependent disease.
Topics: 3-alpha-Hydroxysteroid Dehydrogenase (B-Specific); Androgens; Androstane-3,17-diol; Animals; Cells, Cultured; Dihydrotestosterone; Fatty Acid Synthases; Humans; Male; NADH, NADPH Oxidoreductases; Prostate; Prostatic Diseases; Receptors, Androgen; Transcriptional Activation; Transfection | 2006 |